Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 4.17%.

Results: Adjusted Earnings Per Share increased 150% to $0.05 in the quarter versus EPS of $0.02 in the year-earlier quarter.

Revenue: Rose 0.39% to $10.3 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Cumberland Pharmaceuticals, Inc. reported adjusted EPS income of $0.05 per share. By that measure, the company met the mean analyst estimate of $0.05. It beat the average revenue estimate of $10 million.

Quoting Management: “Our progress during the first quarter included top line results from three new Caldolor studies and new international partnerships for India and Indonesia,” said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. “We were also pleased with the first quarter financial results maintaining revenues from the prior year quarter, while significantly increasing our net income through the efficient management of our expenses.”